DV
Dividend Vision

BWAY — Brainsway Ltd

Brainsway Ltd (BWAY)

Total return is 194.3% over the past 7.3 years, 4.2 points behind SPY at 198.5%. Its deepest 1-year drawdown was 19.1%.

BWAY is an equity fund holding Brainsway Ltd stock, a medical device company focused on non-invasive neuromodulation treatments. The fund does not currently pay distributions and lacks publicly available yield data, expense ratio information, and significant asset under management details. This holding appeals primarily to investors seeking exposure to specialized healthcare technology rather than those focused on dividend income.

BWAY key facts

Asset type
Stock
Asset class
Equity
Inception date
04/17/2019
Last close
$16.32
Market cap
$631,235,584
Average volume
121000.0
Beta
0.153
Payout ratio
0.0
P/E ratio
71.5
Forward P/E
37.4532
EPS
$0.22